Emerging Intraoperative Imaging Modalities to Improve Surgical Precision

Abstract

Intraoperative imaging (IOI) is performed to guide delineation and localization of regions of surgical interest. While oncological surgical planning predominantly utilizes x-ray computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (US), intraoperative guidance mainly remains on surgeon interpretation and pathology for confirmation. Over the past decades however, intraoperative guidance has evolved significantly with the emergence of several novel imaging technologies, including fluorescence-, Raman, photoacoustic-, and radio-guided approaches. These modalities have demonstrated the potential to further optimize precision in surgical resection and improve clinical outcomes for patients. Not only can these technologies enhance our understanding of the disease, they can also yield large imaging datasets intraoperatively that can be analyzed by deep learning approaches for more rapid and accurate pathological diagnosis. Unfortunately, many of these novel technologies are still under preclinical or early clinical evaluation. Organizations like the Intra-Operative Imaging Study Group of the European Society for Molecular Imaging (ESMI) support interdisciplinary interactions with the aim to improve technical capabilities in the field, an approach that can succeed only if scientists, engineers, and physicians work closely together with industry and regulatory bodies to resolve roadblocks to clinical translation. In this review, we provide an overview of a variety of novel IOI technologies, discuss their challenges, and present future perspectives on the enormous potential of IOI for oncological surgical navigation.

A Raman Imaging Approach Using CD47 Antibody-Labeled SERS Nanoparticles for Identifying Breast Cancer and Its Potential to Guide Surgical Resection

“…More recently, image guided surgery has generated quite a bit of interest in the field of molecular imaging, with several investigators assessing various contrast agents along with various imaging techniques [ 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 ]. Both preclinical and clinical studies have shown the benefits that image guidance can offer during all sorts of surgical applications.…”

Rapid Target Binding and Cargo Release of Activatable Liposomes Bearing HER2 and FAP Single-Chain Antibody Fragments Reveal Potentials for Image-Guided Delivery to Tumors

“…Optical fluorescence imaging in combination with drug delivery systems unifies properties that can advance image-guided medicine. These features can be exploited for example to promote early cancer diagnosis based on fluorescence imaging and to enhance the real-time visualization of tumor margins during oncologic surgery [ 1 , 2 ]. Due to their biocompatibility, liposomes which are lipidic nanovesicles that mimic biological membranes are widely used for the delivery of drugs or contrast agents, both in clinical and preclinical setups [ 3 , 4 , 5 ].…”

A Compact High-Speed Image-Based Method for Measuring the Longitudinal Motion of Living Tissues

“…It is widely recognized that intraoperative diagnosis technologies contribute to minimize surgical damage, preserve normal tissue and reduce the rate of recurrence for tumor resection surgery [1][2][3][4][5]. Optical imaging is characterized by low cost, nonionizing radiation and simple and high resolution [6][7][8], which is promising for design of an intraoperative diagnosis instrument.…”